Literature DB >> 28633095

Development and validation of the Polish version of the Urogenital Distress Inventory short form and the Incontinence Impact Questionnaire short form.

Katarzyna A Skorupska1, Pawel Miotla2, Agnieszka Kubik-Komar3, Pawel Skorupski2, Tomasz Rechberger2.   

Abstract

OBJECTIVE: The Incontinence Impact Questionnaire (IIQ) measures the impact of urinary incontinence on activities, roles, and emotional states of women, whereas the Urogenital Distress Inventory (UDI) measures how troubling the symptoms are. The aim of this study was to develop and assess the effectiveness of a Polish version of the IIQ and UDI. STUDY
DESIGN: The translation into Polish followed standardized procedures. 206 women aged between 31 and 83 years were included into the study. All patients were recruited from women attending the Outpatient Clinic of the 2nd Gynecology Department of the Medical University in Lublin. SUI was observed in 116 cases; OAB in 16 patients and 24 had MUI (confirmed by medical history, bladder diary and urodynamic investigation). 50 healthy women served as control. All patients completed the Polish version of the ICIQ - 'the gold standard' in UI diagnosis - as well as the newly translated Polish versions of the UDI-6 and IIQ-7 questionnaires at baseline. Moreover, 116 women repeated the UDI-6 and IIQ-7 self-assessment again 7days later.
RESULTS: The internal consistency was tested by calculating Cronbach's alpha, using baseline scores. The high reliability of the scale indicates a value greater than 0.7. The reliability was calculated by way of the Intraclass Correlation (ICC) and was considered acceptable when ICC was≥0.7. In fact, ICC in all investigated groups was >0.95. The Cronbach's alpha values were as follows: for SUI patients - 0.74; for OAB - 0.78; and for MUI - 0.28 (the UDI-6 total score for the whole study group was 0.72). Cronbach's alpha total score for IIQ-7-0.89 (SUI group - 0.89; OAB group - 0.93; and MUI group - 0.77). Finally, the Cronbach's alpha total score for the ICIQ Questionnaire was 0.73 (SUI group - 0.71; OAB group - 0.65 and MUI group - 0.81).
CONCLUSIONS: The Polish versions of the UDI-6 and IIQ-7 Questionnaires are reliable, valid, and responsive instruments for assessing the severity of symptoms and quality of life in females suffering from urinary incontinence.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Urogenital distress inventory incontinence impact questionnaire; Validation

Mesh:

Year:  2017        PMID: 28633095     DOI: 10.1016/j.ejogrb.2017.06.024

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire : Correlation of the OABSS with urodynamic study and the UDI-6 and IIQ-7 questionnaires.

Authors:  Andrzej Wróbel; Katarzyna Skorupska; Ewa Rechberger; Andrzej Woźniak; Pawel Miotla; Agnieszka Kubik-Komar; Pawel Skorupski; Tomasz Rechberger
Journal:  Int Urogynecol J       Date:  2019-08-08       Impact factor: 2.894

2.  Identification of the Urogenital Distress Inventory-6 and the Incontinence Impact Questionnaire-7 cutoff scores in urinary incontinent women.

Authors:  Katarzyna Skorupska; Magdalena Emilia Grzybowska; Agnieszka Kubik-Komar; Tomasz Rechberger; Pawel Miotla
Journal:  Health Qual Life Outcomes       Date:  2021-03-16       Impact factor: 3.186

3.  Construction of a Prognostic Score for Ultrasound Evaluation of the Transobturator Sling for Stress Urinary Incontinence.

Authors:  Espada-Gonzalez Cristina; Sabonet-Morente Lorena; Perez-Gonzalez Rita; Gonzalez-Mesa Ernesto Santiago; Jimenez-Lopez Jesus Salvador
Journal:  J Clin Med       Date:  2022-02-27       Impact factor: 4.241

4.  Physiotherapy according to the BeBo Concept as prophylaxis and treatment of urinary incontinence in women after natural childbirth.

Authors:  Aneta Śnieżek; Dorota Czechowska; Marta Curyło; Jacek Głodzik; Paweł Szymanowski; Anna Rojek; Anna Marchewka
Journal:  Sci Rep       Date:  2021-09-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.